Lilly Psoriasis Trial Backs Immunometabolic Treatment Strategy
Lilly's psoriasis trial validates pairing skin-clearance endpoints with cardiometabolic measures, reframing psoriasis as a systemic immunometabolic disease with broader value.
Topic
Immunometabolism
Topic